Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to RYTM Full portfolio

Position in RYTM

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$12,794,208
+$479,170 QoQ
Shares Held
115,232
-18.6% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 46% Shared 0% None 54%

Common Shares in RYTM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. RYTM ranks #35 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in RYTM

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,794,208 115,232
2026-03-31 $12,315,038 141,601
2025-12-31 $13,821,325 129,123
2025-09-30 $11,789,773 116,742
2025-06-30 $2,324,064 36,779
2025-03-31 $2,318,972 43,779
2024-12-31 $2,728,744 48,745
2024-09-30 $1,742,700 33,264
2024-06-30 $1,070,022 26,060
2024-03-31 $1,220,128 28,159
2023-12-31 $1,243,396 27,048
2023-09-30 $629,336 27,452
2023-06-30 $399,469 24,225
2023-03-31 $100,724 5,646
2022-12-31 $164,411 5,646
2022-03-31 $2,616,353 227,114
2021-12-31 $267,004 26,754
2021-09-30 $347,905 26,639
2021-06-30 $584,971 29,876
2021-03-31 $834,398 39,229
2020-12-31 $774,704 26,058
2020-09-30 $418,837 19,328
2020-06-30 $401,667 18,012
2020-03-31 $158,911 10,441